Anika Therapeutics Retains Sharon Merrill Associates as Investor Relations Counsel; Boston-based IR Firm Implements Program to Generate Awareness of Anika's Performance and Growth Prospects.BOSTON -- Sharon Merrill Associates, Inc., a Boston-based provider of results-driven investor relations Investor relations The process by which the corporation communicates with its investors. and corporate communications services, today announced that it has been retained by Anika Therapeutics, Inc. (Nasdaq: ANIK ANIK Canadian COMSAT ), which develops, manufactures and commercializes therapeutic products and devices intended to promote the repair, protection and healing of bone, cartilage and soft tissue. Sharon Merrill Associates is providing investor relations counsel and implementing a strategic investor relations program on behalf of the company. "We are delighted to be working with Anika Therapeutics," said Maureen Wolff-Reid, president of Sharon Merrill Associates. "We look forward to helping Anika increase its visibility with the investment community as the company drives product sales growth and leverages its innovative development pipeline." "Sharon Merrill Associates has a strong track record of success in helping companies attract the attention of the investment community," said President and Chief Executive Officer of Anika Therapeutics, Charles H. Sherwood, Ph.D. "We are excited about working with Sharon Merrill Associates to communicate our performance and growth prospects." About Anika Therapeutics, Inc. Headquartered in Woburn, Mass., Anika Therapeutics, Inc. (www.anikatherapeutics.com) develops, manufactures and commercializes therapeutic products for tissue protection and healing. These products are based on hyaluronic acid (HA), a naturally occurring, biocompatible biocompatible /bio·com·pat·i·ble/ (-kom-pat´i-b'l) being harmonious with life; not having toxic or injurious effects on biological function. polymer found throughout the body. Anika products include OrthoVisc(R), a treatment for osteoarthritis osteoarthritis or osteoarthrosis or degenerative joint disease Most common joint disorder, afflicting over 80% of those who reach age 70. It does not involve excessive inflammation and may have no symptoms, especially at first. of the knee available internationally and marketed in the U.S. by DePuy Mitek, and Hyvisc(R), a treatment for equine osteoarthritis marketed in the U.S. by Boehringer Ingelheim Vetmedica, Inc. Anika manufactures Amvisc(TM) and Amvisc Plus(TM), HA viscoelastic Adj. 1. viscoelastic - having viscous as well as elastic properties natural philosophy, physics - the science of matter and energy and their interactions; "his favorite subject was physics" products for ophthalmic surgery. It also produces STAARVISC(TM)-II, which is distributed by STAAR STAAR Second Time Around Aussie Rescue, Inc. (Bryan, TX) STAAR Space Technology Applications Astronomy & Rocket Research (Scottish Rocket Programme) Surgical company and Shellgel(TM) for Cytosol cytosol /cy·to·sol/ (sit´ah-sol) the liquid medium of the cytoplasm, i.e., cytoplasm minus organelles and nonmembranous insoluble components.cytosol´ic cy·to·sol n. Ophthalmics, Inc. About Sharon Merrill Associates, Inc. Sharon Merrill Associates (SMA (1) See SMA connector. (2) (Shared Memory Architecture) See shared video memory. (3) (Software Maintenance Association) A membership organization that began in 1985 and ended in 1996. ) is one of America's preeminent investor relations and corporate communications firms. The firm serves private and public companies in a broad range of industries. SMA's mission for these clients is to enhance their access to capital on favorable terms, capture the attention of the investment community and generate positive coverage in the business media. SMA's principals have earned wide recognition for innovative approaches to investor targeting, as pioneers in Web-based IR and for leadership in IR best practices as officers and board members of the National Investor Relations Institute The National Investor Relations Institute, known as "NIRI", is the professional association for investor relations professionals in the United States. NIRI was founded in 1969 and has more than 4,500 members, both from the United States and other countries. , Financial Executives International, and the National Association of Corporate Directors. SMA won the 2006, 2005 and 2004 Bell Ringer Award for Investor Relations and overall "Best in Show" Super Bell award in 2004. To learn more about SMA, please visit the company's website at www.InvestorRelations.com. |
|
||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion